Literature DB >> 24238775

Tissue distribution of 35S-labelled perfluorobutanesulfonic acid in adult mice following dietary exposure for 1-5 days.

Jasna Bogdanska1, Maria Sundström2, Ulrika Bergström3, Daniel Borg4, Manuchehr Abedi-Valugerdi5, Åke Bergman6, Joseph DePierre7, Stefan Nobel8.   

Abstract

Perfluorobutanesulfonyl fluoride (PBSF) has been introduced as a replacement for its eight-carbon homolog perfluorooctanesulfonyl fluoride (POSF) in the manufacturing of fluorochemicals. Fluorochemicals derived from PBSF may give rise to perfluorobutanesulfonic acid (PFBS) as a terminal degradation product. Although basic mammalian toxicokinetic data exist for PFBS, information on its tissue distribution has only been reported in one study focused on rat liver. Therefore, here we characterized the tissue distribution of PFBS in mice in the same manner as we earlier examined its eight-carbon homolog perfluorooctanesulfonate (PFOS) to allow direct comparisons. Following dietary exposure of adult male C57/BL6 mice for 1, 3 or 5d to 16 mg (35)S-PFBS kg(-1) d(-1), both scintillation counting and whole-body autoradiography (WBA) revealed the presence of PFBS in all of the 20 different tissues examined, demonstrating its ability to leave the bloodstream and enter tissues. After 5d of treatment the highest levels were detected in liver, gastrointestinal tract, blood, kidney, cartilage, whole bone, lungs and thyroid gland. WBA revealed relatively high levels of PFBS in male genital organs as well, with the exception of the testis. The tissue levels increased from 1 to 3 d of exposure but appeared thereafter to level-off in most cases. The estimated major body compartments were whole bone, liver, blood, skin and muscle. This exposure to PFBS resulted in 5-40-fold lower tissue levels than did similar exposure to PFOS, as well as in a different pattern of tissue distribution, including lower levels in liver and lungs relative to blood.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoradiography; Liquid scintillation; Mice; PFBS; PFOS; Perfluorobutanesulfonic acid; Perfluorooctanesulfonic acid; Tissue distribution; WBA; perfluorobutanesulfonic acid; perfluorooctanesulfonic acid; whole-body autoradiography

Mesh:

Substances:

Year:  2013        PMID: 24238775     DOI: 10.1016/j.chemosphere.2013.09.062

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  8 in total

Review 1.  Assessing the bioaccumulation potential of ionizable organic compounds: Current knowledge and research priorities.

Authors:  James M Armitage; Russell J Erickson; Till Luckenbach; Carla A Ng; Ryan S Prosser; Jon A Arnot; Kristin Schirmer; John W Nichols
Journal:  Environ Toxicol Chem       Date:  2016-12-19       Impact factor: 3.742

2.  Perfluorobutanesulfonic acid (PFBS) potentiates adipogenesis of 3T3-L1 adipocytes.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Food Chem Toxicol       Date:  2018-07-18       Impact factor: 6.023

3.  Perfluorooctanesulfonic acid (PFOS) and perfluorobutanesulfonic acid (PFBS) impaired reproduction and altered offspring physiological functions in Caenorhabditis elegans.

Authors:  Yiren Yue; Sida Li; Zhuojia Qian; Renalison Farias Pereira; Jonghwa Lee; Jeffery J Doherty; Zhenyu Zhang; Ye Peng; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Food Chem Toxicol       Date:  2020-08-22       Impact factor: 6.023

4.  Short-chain perfluoroalkyl acids: environmental concerns and a regulatory strategy under REACH.

Authors:  Stephan Brendel; Éva Fetter; Claudia Staude; Lena Vierke; Annegret Biegel-Engler
Journal:  Environ Sci Eur       Date:  2018-02-27       Impact factor: 5.893

Review 5.  Endocrine Disruptor Potential of Short- and Long-Chain Perfluoroalkyl Substances (PFASs)-A Synthesis of Current Knowledge with Proposal of Molecular Mechanism.

Authors:  Katarzyna Mokra
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

6.  Pharmacokinetic profile of Perfluorobutane Sulfonate and activation of hepatic nuclear receptor target genes in mice.

Authors:  Christopher Lau; Jason Rumpler; Kaberi P Das; Carman R Wood; Judith E Schmid; Mark J Strynar; John F Wambaugh
Journal:  Toxicology       Date:  2020-06-10       Impact factor: 4.571

Review 7.  Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine Disruptors.

Authors:  Roberto Toni; Giusy Di Conza; Fulvio Barbaro; Nicoletta Zini; Elia Consolini; Davide Dallatana; Manuela Antoniel; Enrico Quarantini; Marco Quarantini; Sara Maioli; Celeste Angela Bruni; Lisa Elviri; Silvia Panseri; Simone Sprio; Monica Sandri; Anna Tampieri
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

8.  Toxicokinetics of perfluorobutane sulfonate (PFBS), perfluorohexane-1-sulphonic acid (PFHxS), and perfluorooctane sulfonic acid (PFOS) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration.

Authors:  M C Huang; A L Dzierlenga; V G Robinson; S Waidyanatha; M J DeVito; M A Eifrid; C A Granville; S T Gibbs; C R Blystone
Journal:  Toxicol Rep       Date:  2019-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.